In this application, we design experiments aimed to exploit the recent discovery and in our laboratories that interleukin-6(IL-6) is a complete mitogen for human biliary epithelium IL-6 also, is elevated in vivo, in human liver diseases where biliary epithelial cell proliferation is seen, such as alcoholic liver disease and fulminant failure. IL-6 also is a major regulatory protein for hepatocyte growth factor (HGF) and c-met receptor production, which is another complete bile duct cell mitogen. The direct and indirect role of IL-6 in inflammatory liver diseases where prolonged biliary epithelial proliferation play an important role will be investigated by: 1. Use of in vitro cultures of human bile duct epithelium and diseased human liver tissue: We have ready access to normal and diseased human liver tissue from the largest liver transplant center in the world. Approximately 350 diseased livers and normal liver tissue from 30 other cases are available each year. Using these resources we will: A. Characterize in vitro, the effect of lL-6 and two key pro-inflammatory cytokines (IL-1beta on TNF alpha) on human bile duct epithelium responsiveness to HGF and IL-6 and on production of matrix proteins. B. Characterize in vivo, the microenvironment of human livers disease associated and IL-6 elevators where bile ductular proliferation plays an important role ( submassive necrosis and alcoholic liver disease). 2. Use of IL-6 """"""""knockout"""""""" mice and IL-6 transgenic mice: Through collaborations with I. Campbell of Scripps Institute and Clinic and V. Poli, Ph.D., from the Molecular Biology Institute in Rome, Italy, we have available to us mice that over-express IL-6 (transgenics) and mice that are incapable of IL-6 production (knockout), respectively. Using these animals we will: A. Evaluate in vivo, the role of IL-6 in biliary epithelial growth after stimuli that cause bile duct proliferation. B. Use IL-6 antagonists, such as anti-IL6 monoclonal antibodies, suramin or inhibitors of intracellular second signaling molecules to determine if such interventions could have therapeutic implications for patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK049615-05
Application #
6164537
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Doo, Edward
Project Start
1996-03-01
Project End
2002-02-28
Budget Start
2000-03-01
Budget End
2002-02-28
Support Year
5
Fiscal Year
2000
Total Cost
$193,356
Indirect Cost
Name
University of Pittsburgh
Department
Pathology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Specht, Susan; Isse, Kumiko; Nozaki, Isao et al. (2013) SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis. Clin Exp Metastasis 30:877-90
Demetris, Anthony J; Specht, Susan; Nozaki, Isao et al. (2008) Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes. J Hepatol 48:276-88
Lim, Kyu; Han, Chang; Xu, Lihong et al. (2008) Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. Cancer Res 68:553-60
Lunz 3rd, John G; Specht, Susan M; Murase, Noriko et al. (2007) Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity. Hepatology 46:1946-59
Demetris, Anthony J; Kelly, Dympna M; Eghtesad, Bijan et al. (2006) Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 30:986-93
Demetris, A J; Fontes, Paulo; Lunz 3rd, John G et al. (2006) Wound healing in the biliary tree of liver allografts. Cell Transplant 15 Suppl 1:S57-65
Demetris, A-J; Lunz 3rd, John-G; Specht, Susan et al. (2006) Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol 12:3512-22
Han, Chang; Demetris, A Jake; Stolz, Donna B et al. (2006) Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway. J Biol Chem 281:24831-46
Toyokawa, Hideyoshi; Nakao, Atsunori; Stolz, Donna B et al. (2006) 3D-confocal structural analysis of bone marrow-derived renal tubular cells during renal ischemia/reperfusion injury. Lab Invest 86:72-82
Nozaki, Isao; Lunz 3rd, John G; Specht, Susan et al. (2005) Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab Invest 85:109-23

Showing the most recent 10 out of 43 publications